These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9892504)

  • 1. Intracellular localisation of the Ro 52kD auto-antigen in HeLa cells visualised with green fluorescent protein chimeras.
    Pourmand N; Blange I; Ringertz N; Pettersson I
    Autoimmunity; 1998; 28(4):225-33. PubMed ID: 9892504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 52 kD Ro/SS-A localizes to punctate structures in the cytoplasm of epithelial cells.
    McCauliffe DP; Woźniacka A
    Cell Mol Biol Lett; 2003; 8(1):133-40. PubMed ID: 12655367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
    Barcellos KS; Nonogaki S; Enokihara MM; Teixeira MS; Andrade LE
    J Rheumatol; 2007 Jun; 34(6):1283-92. PubMed ID: 17552056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target antigens of the SSA/Ro and SSB/La system.
    Ben-Chetrit E
    Am J Reprod Immunol; 1992; 28(3-4):256-8. PubMed ID: 1285896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-protein interaction of the Ro-ribonucleoprotein particle using multiple antigenic peptides.
    Scofield RH; Kurien BT; Zhang F; Mehta P; Kaufman K; Gross T; Bachmann M; Gordon T; Harley JB
    Mol Immunol; 1999; 36(15-16):1093-106. PubMed ID: 10698311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.
    Scofield RH; Farris AD; Horsfall AC; Harley JB
    Arthritis Rheum; 1999 Feb; 42(2):199-209. PubMed ID: 10025913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of the Ro/SSA antigen and autoanti-Ro/SSA response: evidence of the four antigenically distinct forms.
    Itoh Y; Rader MD; Reichlin M
    Clin Exp Immunol; 1990 Jul; 81(1):45-51. PubMed ID: 2379322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
    Ohlsson M; Jonsson R; Brokstad KA
    Scand J Immunol; 2002 Nov; 56(5):456-69. PubMed ID: 12410795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects.
    Mavragani CP; Tzioufas AG; Moutsopoulos HM
    Int Arch Allergy Immunol; 2000 Sep; 123(1):46-57. PubMed ID: 11014971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal autoimmune response to recombinant Ro/SSA and La/SSB proteins in Japanese neonatal lupus erythem atosus.
    Miyagawa S; Fukumoto T; Hashimoto K; Hachiya T; Yoshioka A; Shirai T
    Autoimmunity; 1995; 21(4):277-82. PubMed ID: 8852519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A calreticulin-like protein co-purifies with a '60 kD' component of Ro/SSA, but is not recognized by antibodies in Sjögren's syndrome sera.
    Lu J; Willis AC; Sim RB
    Clin Exp Immunol; 1993 Dec; 94(3):429-34. PubMed ID: 8252803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UVB light and 17-beta-estradiol have different effects on the mRNA expression of Ro/SSA and La/SSB autoantigens in HaCaT cells.
    Szegedi A; Irinyi B; Bessenyei B; Márka M; Hunyadi J; Semsei I
    Arch Dermatol Res; 2001 Jun; 293(6):275-82. PubMed ID: 11480586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein.
    Itoh Y; Reichlin M
    Autoimmunity; 1992; 14(1):57-65. PubMed ID: 1284379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Zn2+ binding domain of the human Ro 52 kDa protein is a target for conformation-dependent autoantibodies.
    Pourmand N; Pettersson I
    J Autoimmun; 1998 Feb; 11(1):11-7. PubMed ID: 9480719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. La autoantigen translocates to cytoplasm after cleavage during granzyme B-mediated cytotoxicity.
    Huang M; Ida H; Arima K; Nakamura H; Aramaki T; Fujikawa K; Tamai M; Kamachi M; Kawakami A; Yamasaki H; Origuchi T; Eguchi K
    Life Sci; 2007 Oct; 81(19-20):1461-6. PubMed ID: 17945310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genes.
    Itoh K; Itoh Y; Frank MB
    J Clin Invest; 1991 Jan; 87(1):177-86. PubMed ID: 1985094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of the 52-kD Ro/SSA autoantigen.
    Frank MB; Itoh K; McCubbin V
    Clin Exp Immunol; 1994 Mar; 95(3):390-6. PubMed ID: 8137537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus.
    Buyon JP; Ben-Chetrit E; Karp S; Roubey RA; Pompeo L; Reeves WH; Tan EM; Winchester R
    J Clin Invest; 1989 Aug; 84(2):627-34. PubMed ID: 2760204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens.
    Veldhoven CH; Pruijn GJ; Meilof JF; Thijssen JP; Van der Kemp AW; Van Venrooij WJ; Smeenk RJ
    Clin Exp Immunol; 1995 Jul; 101(1):45-54. PubMed ID: 7621591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.